Sophie Wen (Australia)

Queensland Children's Hospital Infection Management Prevention Service
Dr Sophie Wen is a Paediatric Infection specialist based at Queensland Children's Hospital, in Brisbane, Australia. She is currently undertaking a PhD with the University of Queensland. Dr Wen's research interests include invasive infections in children and optimising paediatric clinical trials.

Author Of 1 Presentation

EPIDEMIOLOGY AND CLINICAL OUTCOMES OF GRAM-NEGATIVE BLOODSTREAM INFECTIONS IN HOSPITALISED AUSTRALIAN CHILDREN

Date
Wed, 11.05.2022
Session Time
13:40 - 15:10
Session Type
Parallel Symposium
Room
NIKOS SKALKOTAS HALL
Lecture Time
14:57 - 15:07

Abstract

Backgrounds:

Gram-negative bloodstream infections (GNBSI) in children are of increasing concern, being associated with significant mortality and antimicrobial resistance. There are few population-based data to describe the risk factors and clinical outcomes from GNBSI in children. We established a surveillance study of GNBSI through the Australian Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Here are the findings from the first 2 years (2019-2020).

Methods

Active surveillance commenced in five Australian tertiary paediatric hospitals in January 2019. Patients aged <18 years with a pathogenic Gram-negative organism in blood culture and suspicion of systemic infection were included. Clinical features, risk factors, antimicrobial therapy and outcomes including length of hospital and intensive care unit (ICU) stay, 30-day and in-hospital mortality, and complications associated with hospitalisation were recorded.

Results:

From January 2019 to December 2020, there were 639 episodes of GNBSIs in 565 children, and 679 isolates identified. The median age was 2.9 years (IQR 0.5-7.7 years) and 59% were male. 53% were community onset and 72% occurred in children with comorbidities. Malignancy was the most common comorbidity (36%). Intravascular device was the source for 26%. Microbiology is shown in Figure 1. 13% were already in ICU at time of GNBSI onset with an additional 13% requiring ICU admission. Median duration of hospitalisation was 14 days (IQR 8-35 days). There were 42 deaths from all causes (7%) during admission, with GNBSI contributory to 60% of deaths. Nine deaths occurred within 30-days (1.4%), with no significant differences in those with/without comorbidities (1.3% vs 1.8% p-value=0.71).

picture 1.png

Conclusions/Learning Points:

GNBSI in children are associated with significant mortality and over half are healthcare associated, with a notable proportion requiring ICU admission.

Hide

Presenter of 1 Presentation

EPIDEMIOLOGY AND CLINICAL OUTCOMES OF GRAM-NEGATIVE BLOODSTREAM INFECTIONS IN HOSPITALISED AUSTRALIAN CHILDREN

Date
Wed, 11.05.2022
Session Time
13:40 - 15:10
Session Type
Parallel Symposium
Room
NIKOS SKALKOTAS HALL
Lecture Time
14:57 - 15:07

Abstract

Backgrounds:

Gram-negative bloodstream infections (GNBSI) in children are of increasing concern, being associated with significant mortality and antimicrobial resistance. There are few population-based data to describe the risk factors and clinical outcomes from GNBSI in children. We established a surveillance study of GNBSI through the Australian Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Here are the findings from the first 2 years (2019-2020).

Methods

Active surveillance commenced in five Australian tertiary paediatric hospitals in January 2019. Patients aged <18 years with a pathogenic Gram-negative organism in blood culture and suspicion of systemic infection were included. Clinical features, risk factors, antimicrobial therapy and outcomes including length of hospital and intensive care unit (ICU) stay, 30-day and in-hospital mortality, and complications associated with hospitalisation were recorded.

Results:

From January 2019 to December 2020, there were 639 episodes of GNBSIs in 565 children, and 679 isolates identified. The median age was 2.9 years (IQR 0.5-7.7 years) and 59% were male. 53% were community onset and 72% occurred in children with comorbidities. Malignancy was the most common comorbidity (36%). Intravascular device was the source for 26%. Microbiology is shown in Figure 1. 13% were already in ICU at time of GNBSI onset with an additional 13% requiring ICU admission. Median duration of hospitalisation was 14 days (IQR 8-35 days). There were 42 deaths from all causes (7%) during admission, with GNBSI contributory to 60% of deaths. Nine deaths occurred within 30-days (1.4%), with no significant differences in those with/without comorbidities (1.3% vs 1.8% p-value=0.71).

picture 1.png

Conclusions/Learning Points:

GNBSI in children are associated with significant mortality and over half are healthcare associated, with a notable proportion requiring ICU admission.

Hide